Is GBT stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Global Blood Therapeutics 10 years ago, but if you had invested on Wednesday 12th of August 2015 when the price was $43.11, you would have made a profit of $25.38 per share or 58.87%
Yes, the average daily trading liquidity for Global Blood Therapeutics is $156.55 million. You should therefore be able to get in and out of your positions relatively fast.
Global Blood Therapeutics has much of the business financed by loans. This puts the company at high risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Global Blood Therapeutics to be high [1 out of 1]